Approval · Notice of Compliance 9236 · 2007
GLUCOBAY: Notice of Compliance 9236
Issued December 11, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9236
- Date
- December 11, 2007
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph: warnings and precautions, adverse reactions, action and clinical pharmacology, clinical trials
- Therapeutic class
- Oral antidiabetic agent; alpha-glucosidase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLUCOBAY | Not yet assigned | — |